SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor ...

Hematology-oncology-trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle cell care (43%) despite no differences in ...

It's unlikely that Savannah Guthrie's missing mom, Nancy, is still alive, according to a former special deputy U.S. marshal. Spencer went on to tell viewers that due to the grim statistic, you should ...

Modern railways no longer rely on the jointed track sections that once produced the familiar “clickety-clack” sound of passing trains. Instead, most rail systems now use continuous welded rail, where ...

Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse ...

According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...

Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...

Amini: From a radiation standpoint, this has changed the landscape of our field. A large proportion of my practice is stage IV disease, where patients who are on these excellent systemic therapies are ...

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with ...

Tenosynovial giant cell tumor is a locally aggressive tumor of the joint synovium, bursae or tendon sheaths. Although rare and not life-threatening, it can cause significant pain, stiffness and joint ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most ...